VIVUS, INC.
Patent Owner
Stats
- 43 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Aug 08, 2017 most recent publication
Details
- 43 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,084 Total Citation Count
- Oct 30, 1991 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0151,179 Low Dose Topiramate/Phentermine Composition and Methods of Use ThereofJul 06, 16Jun 01, 17[A61K]
2017/0119,730 Combination Therapy for Effecting Weight Loss and Treating ObesityJun 03, 16May 04, 17[A61K]
2016/0250,180 ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITYMay 10, 16Sep 01, 16[A61K]
2016/0045,527 TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONISTAug 13, 15Feb 18, 16[A61K]
2016/0015,730 Treatment of Pulmonary Hypertension with Carbonic Anhydrase InhibitorsJul 22, 15Jan 21, 16[A61K]
2015/0379,328 NETWORK-BASED PATHOLOGY SYSTEM WITH DESKTOP SLIDE SCANNERSep 08, 15Dec 31, 15[H04N, G06F, G02B, G06K]
2015/0328,246 ORALLY ADMINISTRATABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENTMay 15, 15Nov 19, 15[A61K, B29C]
2014/0294,950 METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONSMar 17, 14Oct 02, 14[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9011905 Low dose topiramate/phentermine composition and methods of use thereofSep 24, 14Apr 21, 15[A61K]
9011906 Escalating dosing regimen for effecting weight loss and treating obesitySep 24, 14Apr 21, 15[A61K]
8895057 Escalating dosing regimen for effecting weight loss and treating obesityOct 08, 13Nov 25, 14[A61K]
8895058 Low dose topiramate/phentermine composition and methods of use thereofOct 08, 13Nov 25, 14[A61K]
8580298 Low dose topiramate/phentermine composition and methods of use thereofJun 09, 09Nov 12, 13[A61K]
8580299 Escalating dosing regimen for effecting weight loss and treating obesityJun 09, 09Nov 12, 13[A61K]
8536138 Treatment of pulmonary hypertension with carbonic anhydrase inhibitorsDec 05, 11Sep 17, 13[A61K, A61P]
8071557 Treatment of pulmonary hypertension with carbonic anhydrase inhibitorsJun 13, 07Dec 06, 11[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0310,446 Low Dose Topiramate/Phentermine Composition and Methods of Use ThereofAbandonedDec 15, 15Oct 27, 16[A61K]
2016/0022,630 ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITYAbandonedOct 08, 15Jan 28, 16[A61K]
2015/0313,870 LOW DOSE TOPIRAMATE / PHENTERMINE COMPOSITION AND METHODS OF USE THEREOFAbandonedApr 06, 15Nov 05, 15[A61K]
2015/0231,110 TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENTAbandonedMay 06, 15Aug 20, 15[A61K]
2015/0209,325 Escalating Dosing Regimen for Effecting Weight Loss and Treating ObesityAbandonedApr 06, 15Jul 30, 15[A61K]
2015/0025,134 Compositions and Methods for the Treatment of Sleep ApneaAbandonedOct 09, 14Jan 22, 15[A61K]
2014/0308,346 COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITYAbandonedJun 27, 14Oct 16, 14[A61K]
2014/0288,944 METHODS OF REGULATING ACCESS TO QSYMIA TO MITIGATE POTENTIAL DRUG-ASSOCIATED RISKSAbandonedMar 14, 14Sep 25, 14[G09B, G06F]
2014/0094,511 Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active AgentAbandonedOct 17, 13Apr 03, 14[A61K]
2014/0088,162 Treatment of Pulmonary Hypertension with Carbonic Anhydrase InhibitorsAbandonedSep 12, 13Mar 27, 14[A61K]
2011/0262,535 Low Dose Topiramate / Phentermine Composition and Methods of Use ThereofAbandonedJul 01, 11Oct 27, 11[A61K, A61P]
2011/0224,196 TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENTAbandonedJan 07, 11Sep 15, 11[A61K, A61P]
2010/0087,402 Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disordersAbandonedSep 29, 09Apr 08, 10[A61K]
2009/0304,789 NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERSAbandonedJun 09, 08Dec 10, 09[A61K, A61P]
2008/0255,093 COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERSAbandonedApr 29, 08Oct 16, 08[A61K, A61P]
2008/0227,749 CARRAGEENAN-BASED FORMULATIONS AND ASSOCIATED METHODS OF USEAbandonedMar 31, 08Sep 18, 08[A61K, A61P]
2005/0239,742 Carrageenan-based formulations and associated methods of useAbandonedApr 07, 05Oct 27, 05[A61K]
2005/0070,516 As-needed administration of an androgenic agent to enhance female desire and responsivenessAbandonedNov 16, 04Mar 31, 05[A61K]
2004/0044,080 Treatment of dyspareunia with topically administered nitroglycerin formulationsAbandonedApr 04, 03Mar 04, 04[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.